1986. Switching to DOR/3TC/TDF Improves Renal Function and Decreases Lipid Levels in People Living With HIV: a Real-Life Multicentric Study

BACKGROUND: Pivotal studies on Doravirine (DOR) showed its high tolerability and effectiveness, even on resistant strains. Therefore, DOR and its single tablet combination treatment DOR/lamivudine (3TC)/tenofovir disoproxil fumarate (TDF) has been referred to as a cardiovascular-safe drug. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Micali, Cristina, Russotto, Ylenia, Doctor, Medical, Francesco Pellicanò, Giovanni, Panella, Letizia, Albanese, Antonio, Santoro, Laura, Agata Sofia, Sonia, Pantò, Grazia, Coco, Mariagiovanna, Guarneri, Alessandro, Iacobello, Carmelo, Paternò Raddusa, Michele Salvatore, Ceccarelli, Manuela, Marino, Andrea, Maurizio Celesia, Benedetto, Santi Cacopardo, Bruno, Montineri, Arturo, Frasca, Chiara, Colpani, Agnese, De Vito, Andrea, Madeddu, Giordano, Alibrandi, Angela, Venanzi Rullo, Emmanuele, Nunnari, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677050/
http://dx.doi.org/10.1093/ofid/ofad500.113

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677050/
http://dx.doi.org/10.1093/ofid/ofad500.113

Ejemplares similares